DUBLIN - Nov. 16, 2016 - Medtronic plc (NYSE:MDT) announces the release of its 2016 Integrated Performance Report. The report highlights - for the first time - the combined financial, social, and environmental impact of Medtronic after acquiring Covidien in 2015.

The FY 2016 Integrated Performance Report details the company's commitment to addressing business and industry challenges. Based on the Global Reporting Initiative (GRI) G4 Guidelines, it's organized around the Medtronic sustainability material issues:

• Access to Care
• Product Quality
• Product Stewardship
• Responsible Sourcing
• Ethics in Sales and Marketing

A tenet of the Medtronic Mission - to maintain good citizenship as a company - drives a sense of purpose and responsibility to not only deliver the highest quality products, therapies, and services to patients, but to also support healthy communities in the areas in which it operates.        

In Fiscal Year 2016, Medtronic:

• Delivered strong financial results with $28.8 billion in revenue and $3.5 billion in net earnings.
• Invested $2.2 billion in research and development (R&D), representing 7.7 percent of net sales.
• Donated more than 2 percent of pre-tax profits - $114.6 million - to charitable causes.
• Increased healthcare capacity and access by investing more than $152 million in training for approximately 60,000 medical professionals.
• Continued to meet our goal to reduce operational energy use and greenhouse gas emissions by 15 percent by 2020 from an FY2013 baseline.

The report and Global Reporting Initiative (GRI) Supplement is available for download at www.medtronic.com/SustainabilityReport.

About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 88,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements in this release or the 2016 Integrated Performance Report are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

-end-

Contacts:
Fernando Vivanco
Public Relations
+1-763-505-3780

Ryan Weispfenning
Investor Relations
+1-763-505-4626